Chloroquine inhibits alpha1B-adrenergic action in hepatocytes

European Journal of Pharmacology
J Adolfo García-Sáinz, A Mendoza-Mendoza

Abstract

Noradrenaline increased phosphorylase a activity through activation of alpha1B-adrenoceptors in rat hepatocytes. Such effect was inhibited by chloroquine (Ki approximately 55 nM) and only slightly reduced by high concentrations of primaquine. Chloroquine did not inhibit the activation of phosphorylase a induced by vasopressin or angiotensin II. Binding competition experiments using [3H]prazosin showed that both chloroquine and primaquine interact with alpha1B-adrenoceptors, but only at very high concentrations. This indicates that the ability of chloroquine to block the alpha1B-adrenergic action was not due to antagonism at the receptor level. Noradrenaline increased phosphatidylinositol resynthesis and inositol trisphosphate production; these effects were inhibited by chloroquine and phorbol 12-myristate 13-acetate. Staurosporine and Ro 31-8220 (3-[1-[3-(amidinothio)propyl-1H-indol-3-yl]-3-(1-methyl-1H-indol-3 -yl)maleimide), reduced the inhibitions induced by the active phorbol ester and the antimalarial drug on adrenergic-stimulated phosphatidylinositol resynthesis. Similarly, staurosporine blocked the inhibitory actions of chloroquine and phorbol 12-myristate 13-acetate on noradrenaline-stimulated inositol trisphosphate pro...Continue Reading

References

Jul 31, 1992·Biochemical and Biophysical Research Communications·J A García-SáinzC González-Espinosa
Nov 27, 1991·Biochemical and Biophysical Research Communications·P Dieter, E Fitzke
Sep 1, 1988·Molecular and Cellular Biochemistry·S J SulakheS Tran
Jan 1, 1986·Annual Review of Biochemistry·I MellmanA Helenius
Sep 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·L M Leeb-LundbergM G Caron
May 15, 1985·The Biochemical Journal·J A García-SáinzM A Martínez-Olmedo
Jan 1, 1980·Physiological Reviews·D A Hems, P D Whitton
Sep 1, 1980·Analytical Biochemistry·P J Munson, D Rodbard
Mar 30, 1984·Biochemical and Biophysical Research Communications·S Corvera, J A García-Sáinz
Apr 14, 1995·The Journal of Biological Chemistry·M I FonsecaR D Brown
Jan 1, 1994·Life Sciences·J A García-SáinzC González-Espinosa
Jan 1, 1994·Annual Review of Pharmacology and Toxicology·K P Minneman, T A Esbenshade
May 1, 1996·Circulation Research·R M GrahamM T Piascik
Jul 1, 1997·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J Hofmann

❮ Previous
Next ❯

Citations

Jul 19, 2014·European Journal of Pharmacology·Martijn L MansonMikael Adner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology
G Gutiérrez-Venegas, J Adolfo García-Sáinz
European Journal of Pharmacology
J Adolfo García-SáinzM Teresa Romero-Avila
© 2022 Meta ULC. All rights reserved